l-carnitine interactions | Linus Pauling Institute What Is L-Carnitine: Benefits, Side
Description
Observations on pathogenesis and rational treatment in 421 patients
Int J Mol Sci
This cell viability experiment was assessed in three replicates for each group
Importantly, this PCOS-like phenotype was ameliorated by either knocking out the speA gene in Bacteroides vulgatus or by administering the ADC inhibitor difluoromethylarginine (DFMA) to reduce agmatine production
